ChromaDex (FRA:OCD1) Beginning Cash Position : €25.14 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is ChromaDex Beginning Cash Position?

ChromaDex's Beginning Cash Position for the quarter that ended in Mar. 2024 was €25.14 Mil.

ChromaDex's quarterly Beginning Cash Position declined from Sep. 2023 (€24.74 Mil) to Dec. 2023 (€24.55 Mil) but then increased from Dec. 2023 (€24.55 Mil) to Mar. 2024 (€25.14 Mil).

ChromaDex's annual Beginning Cash Position increased from Dec. 2021 (€14.78 Mil) to Dec. 2022 (€26.64 Mil) but then declined from Dec. 2022 (€26.64 Mil) to Dec. 2023 (€18.75 Mil).

ChromaDex Beginning Cash Position Historical Data

The historical data trend for ChromaDex's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ChromaDex Beginning Cash Position Chart

ChromaDex Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beginning Cash Position

Get a 7-Day Free Trial

20.35

15.46

14.78

26.64

18.75

ChromaDex Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															19.09	21.36	24.74	24.55	25.14

ChromaDex Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

ChromaDex Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of ChromaDex's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

ChromaDex (FRA:OCD1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ChromaDex Corp (FRA:OCD1) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

CDXC:USA

Address

10900 Wilshire Boulevard, Suite 600, Los Angeles, CA, USA, 90024

Website

https://www.chromadex.com

ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segment namely Consumer Products, Ingredients segment and Analytical Reference Standards and Services. Majority of the revenue is earned from Consumer Products segment.

ChromaDex (FRA:OCD1) Headlines

No Headlines